Freitas, Maria Regina <br/><br/>
Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.  [electronic resource] 

 -  Fundamental & clinical pharmacology  Apr 2009 
 - 169-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1472-8206 
<br/><br/><label>Standard No.: </label>10.1111/j.1472-8206.2008.00658.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--pharmacology<br/>Animals<br/>Calcium--metabolism<br/>Calcium Chloride--pharmacology<br/>Disease Models, Animal<br/>Hypertension--drug therapy<br/>Male<br/>Mesenteric Arteries--drug effects<br/>Muscle Contraction--drug effects<br/>Muscle Proteins--metabolism<br/>Muscle, Smooth, Vascular--drug effects<br/>Myosin-Light-Chain Phosphatase--metabolism<br/>Phosphoproteins--metabolism<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Phosphatase 1--metabolism<br/>Pyridines--pharmacology<br/>Rats<br/>Receptors, Adrenergic, alpha-1--metabolism<br/>Signal Transduction--drug effects<br/>rho-Associated Kinases--antagonists & inhibitors